{ }
UBS has initiated coverage of Celestica Inc. (NYSE:CLS) with a Neutral rating and a $95 price target, citing balanced growth prospects in AI infrastructure despite cyclical demand. The firm is already pricing in over 10% growth over the next decade, exceeding its 2025 revenue growth guidance of 8.3%. Investors are advised to wait for a more favorable entry point.
Celestica (TSE:CLS) has received an upgraded "hold" rating from UBS Group, while TD Securities raised its price target from C$55.00 to C$61.00, maintaining a "buy" rating. The stock has a consensus rating of "Moderate Buy" with an average price target of C$44.00. Recent insider sales totaled over C$23 million, indicating significant trading activity among executives.
Celestica Inc. specializes in developing, manufacturing, and providing hardware platforms and supply chain solutions across two main segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS). The ATS segment includes Aerospace & Defense, Industrial, HealthTech, and Capital Equipment, while CCS focuses on Communication and Enterprise markets, offering a range of services such as design, manufacturing, and systems integration.
UBS Group has initiated coverage of Celestica (NYSE: CLS) with a "neutral" rating and a price target of $95, indicating a potential upside of 3.63%. The stock has received mixed ratings from analysts, with three holding and nine buying, while its recent quarterly earnings surpassed expectations with a revenue increase of 24.8% year-over-year. Institutional investors hold 67.38% of the stock, reflecting strong interest in the technology company's supply chain solutions.
The Tiger Grandcub, led by Glen Kacher, has maintained its status as a top performer, with its long-short fund gaining 5.78% in October, bringing its year-to-date return to 53.26%. Light Street Capital's long-only fund rose 3.84% in October, up 39.85% for the year. The firm remains bullish on AI and semiconductor stocks, with Nvidia and TSMC as major holdings, while also initiating a position in Celestica, which surged 34% in October.
The Healthcare Electronics Contract Manufacturing market is poised for significant growth, driven by technological advancements and increasing demand for medical devices. Key players like Flex Ltd., Jabil Inc., and Sanmina Corporation are focusing on strategic collaborations and innovations to enhance their market presence. The report highlights regional market dynamics, growth opportunities, and the impact of various factors influencing the industry landscape.

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.